Search

Your search keyword '"Messinese S"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Messinese S" Remove constraint Author: "Messinese S"
24 results on '"Messinese S"'

Search Results

1. Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review

Catalog

Books, media, physical & digital resources

6. A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

8. UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer

9. A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid

11. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer

12. Evaluation of cutaneous, oral and intestinal microbiota in patients affected by pemphigus and bullous pemphigoid: A pilot study

13. The COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes.

14. Multiple Sclerosis Treatment and Melanoma Development.

15. Evaluation of cutaneous, oral and intestinal microbiota in patients affected by pemphigus and bullous pemphigoid: A pilot study.

16. New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?

17. From patients' needs to treatment outcomes in psoriasis: Results from the 'pSORRIDI' experience.

18. Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.

19. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.

20. Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases.

21. Weekly low-dose docetaxel in advanced hormone-resistant prostate cancer patients previously exposed to chemotherapy.

22. Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens.

23. Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens.

24. Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma.